Global Pharmaceutical Continuous Manufacturing Market To Reach USD 3.24 billion by 2028

The global pharmaceutical continuous manufacturing market was valued at nearly USD 1.53 billion in 2021 and is expected to rise to just over USD 3.24 billion by 2028, with a CAGR of around 9.6% over the forecast period. Continuous manufacturing is a cutting-edge manufacturing method with the capability to enhance the consistency and quality of drugs at a lower cost. This manufacturing line is run at a constant pace, with end-to-end incorporation of manufacturing processes.

The global pharmaceutical continuous manufacturing market is expected to be mainly driven by the improved efficiency of manufacturing processes presented by continuous processes. The market is also anticipated to be fueled owing to technological developments in continuous manufacturing systems along with the rising backing by the regulatory systems for the continuous manufacturing systems’ adoption. Additionally, there is a reduction in the chances of human errors as it involves a small fraction of human resources in the complete process of production. Consequently, it can be approved efficiently for the manufacturing of precision drugs and medicines with revolutionary therapy designations.

Further, the global market will also witness expansion with the rising investment along with consent from pharmaceutical businesses for advanced technology. Also, the growth prospects in the untapped budding nations and the increasing manufacturing of biologics & large molecules will open up new growth opportunities for the market expansion during the forecast period. In addition, joint ventures & collaborations among the top players and the high development in generic manufacturing will fuel the market growth during the forecast period.

The global pharmaceutical continuous manufacturing market is categorized based on product, application, end-user, and region. By product, the market is bifurcated into semicontinuous systems, integrated continuous systems, and control & software. The application segment of the market includes API manufacturing and final drug product manufacturing. The end-user segment of the market is segregated as contract manufacturing organizations, pharmaceutical companies, and others.

Europe will lead the global pharmaceutical continuous manufacturing market during the forecast period owing to factors like strong demand for ground-breaking technologies from pharmaceutical businesses and the presence of numerous contract manufacturing organizations. Europe’s maximum growth is mainly driven by Germany and the United Kingdom. The region, in 2021, in terms of growth, held more than 35% of the share. This is owing to the early accessibility of modern technologies along with the elevated number of technology suppliers in the region.

Asia Pacific is anticipated to witness rapid growth in the pharmaceutical continuous manufacturing market during the forecast period owing to the rising investments in the biopharmaceutical & pharmaceutical industry and the growing number of CROs (contract research organizations). Further, the escalating focus of leading companies on outspreading their operations in the budding economies will bring several growth avenues in the region. Promising policies in China to encourage the healthcare sector are expected to lift pharmaceutical businesses. Also, numerous businesses are determined to perform continuous bioprocessing, thus boosting the pharmaceutical continuous manufacturing market in China.

Major players operating in the global pharmaceutical continuous manufacturing market include Coperion GmbH, Bosch Packaging Technology, Gebrüder Lödige Maschinenbau GmbH, Hosokawa Micron Corporation, GEA Group AG, Glatt GmbH, Korsch AG, L.B. Bohle Maschinen + Verfahren GmbH, Thermo Fisher Scientific Inc., and Munson Machinery Company, Inc.

Recent Developments

• September 2021, Thermo Fisher will invest USD 82.5 million to increase production capacity at its biologic drug substance manufacturing facility in St. Louis. The investment will increase the company's entire manufacturing capacity two-fold, serving both short- and long-term COVID-19 requirements.
• September 2021, The Johnson & Johnson manufacturing facility in Ringaskiddy, Ireland, endures to expand. The firm has plans to increase the manufacturing capacity with the completion of a USD 354 million. This investment brings the total amount invested in the biologics production plant to USD 176 million.

Browse the full “Pharmaceutical Continuous Manufacturing Market By Product (Integrated Continuous Systems, Semicontinuous Systems, And Control & Software), By Application (Final Drug Product Manufacturing And API Manufacturing), By End User (Pharmaceutical Companies, Contract Manufacturing Organizations, And Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/pharmaceutical-continuous-manufacturing-market

Global pharmaceutical continuous manufacturing market is segmented as follows:

By Product

• Integrated Continuous Systems
• Semicontinuous Systems
• Control & Software

By Application

• Final Drug Product Manufacturing
• API Manufacturing

By End User

• Pharmaceutical Companies
• Contract Manufacturing Organizations
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com